Gregory Shotzberger, a former executive with King Pharmaceuticals, is the new vice president of business development for pharmaceutical firm Icagen.

Shotzberger has more than 20 years of experience in business development related to pharmaceuticals, including licensing, technology institutions and collaborations.

“Greg Shotzberger brings to Icagen an outstanding background in business development within the pharmaceutical industry,” said P. Kay Wagoner, president and chief executive officer of Icagen. “With over twenty years of experience at several of the leading companies in the pharmaceutical industry, Dr. Shotzberger’s expertise will facilitate the establishment of strong partnerships and collaborative agreements, and drive forward the implementation of our strategic goals.”